- Home
- MSEX vs CVAC Comparison
MSEX vs CVAC Comparison
Compare MSEX & CVAC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MSEX
- CVAC
- Stock Information
- Founded
- MSEX 1897
- CVAC 2000
- Country
- MSEX United States
- CVAC Germany
- Employees
- MSEX N/A
- CVAC N/A
- Industry
- MSEX Water Supply
- CVAC Biotechnology: Pharmaceutical Preparations
- Sector
- MSEX Utilities
- CVAC Health Care
- Exchange
- MSEX Nasdaq
- CVAC Nasdaq
- Market Cap
- MSEX 895.1M
- CVAC 818.8M
- IPO Year
- MSEX N/A
- CVAC 2020
- Fundamental
- Price
- MSEX $64.10
- CVAC $2.77
- Analyst Decision
- MSEX Hold
- CVAC Hold
- Analyst Count
- MSEX 3
- CVAC 3
- Target Price
- MSEX $59.33
- CVAC $10.00
- AVG Volume (30 Days)
- MSEX 257.8K
- CVAC 620.8K
- Earning Date
- MSEX 05-07-2025
- CVAC 05-22-2025
- Dividend Yield
- MSEX 2.11%
- CVAC N/A
- EPS Growth
- MSEX 39.94
- CVAC N/A
- EPS
- MSEX 2.47
- CVAC N/A
- Revenue
- MSEX $191,877,000.00
- CVAC $70,565,734.00
- Revenue This Year
- MSEX $10.20
- CVAC $742.57
- Revenue Next Year
- MSEX $6.56
- CVAC N/A
- P/E Ratio
- MSEX $25.72
- CVAC N/A
- Revenue Growth
- MSEX 15.40
- CVAC 75.11
- 52 Week Low
- MSEX $45.42
- CVAC $2.22
- 52 Week High
- MSEX $70.73
- CVAC $5.28
- Technical
- Relative Strength Index (RSI)
- MSEX 68.88
- CVAC 38.24
- Support Level
- MSEX $59.07
- CVAC $2.78
- Resistance Level
- MSEX $61.39
- CVAC $3.33
- Average True Range (ATR)
- MSEX 1.64
- CVAC 0.15
- MACD
- MSEX -0.02
- CVAC -0.00
- Stochastic Oscillator
- MSEX 85.25
- CVAC 8.20
About MSEX Middlesex Water Company
Middlesex Water Co owns and operates regulated water utility and wastewater systems in the U.S. The firm primarily operates in the eastern states of New Jersey, Delaware, and Pennsylvania. The company has two operating segments, Regulated and Non-Regulated. The regulated business includes collecting and distributing water to residential, commercial, industrial, and fire protection consumers. The non-regulated business includes contract services for the operation of private water and wastewater systems. The majority of the company's revenue is derived from the Regulated segment and from residential customers.
About CVAC CureVac N.V.
CureVac is a biopharmaceutical company headquartered in Germany that is developing vaccines and therapies using messenger ribonucleic acid, or mRNA. The company was founded in 2000 and had its initial public offering in August 2020. CureVac had a collaboration with GSK to develop second-generation seasonal influenza and Covid vaccines and an avian influenza vaccine. The company's other pipeline candidates include mRNA vaccines for oncology and molecular therapies spanning tumors, liver, and ocular diseases.